Judge Pauses Nationwide Mifepristone Lawsuit | Boise News

A Texas federal judge has paused a high-stakes lawsuit aiming to remove the abortion drug mifepristone from the market nationwide, delaying any hearing until at least December 1. The FDA requested the pause to continue its safety review, and the judge agreed. The case, initially filed by Republican attorneys general from Florida and Texas in December, sought to revoke the FDA’s original 2000 approval and undo later access expansions — both states backed off after the FDA asked for the delay. If successful, the suit could have made mifepristone unavailable across the country regardless of state laws. The judge also rejected a motion to dismiss the case entirely, with drug manufacturers now stepping in as defendants. GenBioPro, one of the main producers, expects the FDA’s review to reaffirm the drug’s safety, as it did in 2023, and vows to fight legally to preserve reproductive access amid multiple ongoing lawsuits reshaping nationwide access to the medication. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/f95c5af58a2faaf3